Please login to the form below

Not currently logged in

Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more

Roche's Perjeta pertuzumab

E-cigarettes can save lives - Teva gains approval for EpiPen generic

Daily Brief: DeepMind and NHS success in AI, Bayer invests in COPD, Alecensa OK in Scotland

Google DeepMindThe latest from pharma, biotech and healthcare

AI company Sensyne raises £60m in IPO

SensyneUniversity of Oxford-developed tech powers health-focused company

Love Island ads fuel body image problems, warn health leaders

Love IslandCalls for watchdog to regulate cosmetic surgery adverts

‘Common Rulebook’ Brexit plans include medicines – but face backlash

Government compromises could be opposed from both sides

Daily Brief: Brexit reshuffle brings new health minister, Celgene thalassemia success, Wellcome ready to leap into future

Matt HancockA round-up from pharma, biotech and healthcare

Vertex calls NHS England ‘outrageous’ as Orkambi talks stall again

OrkambiPublic row about confidential pricing talks drags on

The NHS at 70: celebrations, renewed reforms and difficult choices

nhs 70Health service remains popular with public, but faces daunting need for radical change

Eminent surgeon Atul Gawande to lead Amazon’s health venture

Surgeon, public health doctor and 'big thinker' on healthcare to lead new venture

The shifting healthcare landscape

Featured jobs

Subscribe to our email news alerts


Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...